TARIS Biomedical Receives $32,000,000 New Financing

  • Feed Type
  • Date
    10/27/2015
  • Company Name
    TARIS Biomedical
  • Mailing Address
    113 Hartwell Avenue Lexington, MA 02421 USA
  • Company Description
    TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products.
  • Website
    http://www.tarisbiomedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $32,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    TARIS will use the proceeds from this current financing to advance an exciting new pipeline that targets a range of high unmet need bladder diseases, initially focusing on bladder cancer and overactive bladder segments.
  • M&A Terms
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Polaris Partners
  • Venture Investor
    RA Capital

Trending on Xconomy